A RANDOMIZED, OPEN-LABEL STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO DIFFERENT SIROLIMUS (SRL) REGIMENS WITH TACROLIMUS (TAC) + MYCOPHENOLATE MOFETIL (MMF) IN DE NOVO RENAL ALLOGRAFT RECIPIENTS: PRELIMINARY 2-YEAR SAFETY RESULTS FROM THE ORION TRIAL: 444
2008
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
7
Citations
NaN
KQI